Search

Robin C Ashmore

from Pittsburgh, PA
Age ~57
Get Report
Also known as:
Robin A Ashmore, Rebecca Huss-Ashmore
Phone and address:
143 Grove Ave, Pittsburgh, PA 15229
(215) 477-7696
Related to:
Walter W Ashmore, 90Ava M Callison, 55Michael BurnettAnn Ashmore, 86Amanda B Greves, 47
Connected to:
Andre B Ashmore, 34Blake D Ashmore, 37Burdene C Ashmore, 124Cassandra J Ashmore, 36Christine M Ashmore, 57Dalton H Ashmore, 55Jason G Ashmore, 52Jo A Ashmore, 83Jon L Ashmore, 89Josie Ashmore, 51

Robin Ashmore Phones & Addresses

  • 143 Grove Ave, Pittsburgh, PA 15229 (215) 477-7696
  • 7528 Brentwood Rd, Philadelphia, PA 19151 (215) 477-7696
  • 532 45Th St, Philadelphia, PA 19104 (215) 387-4051
  • 4804 Trinity St, Philadelphia, PA 19143 (215) 729-3484
  • South Deerfield, MA
  • Los Angeles, CA

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: Associate degree or higher

Resumes

Resumes

Robin Ashmore Photo 1

Biomedical Software Engineer At Neuro Kinetics, Inc.

View page
Position:
Biomedical Software Engineer at Neuro Kinetics, Inc., Biomedical Research Engineer at University of Pittsburgh
Location:
Greater Pittsburgh Area
Industry:
Biotechnology
Work:
Neuro Kinetics, Inc. - Greater Pittsburgh Area since Nov 2012
Biomedical Software Engineer
University of Pittsburgh - Human Rehabilitation and Neuroengineering Laboratory since Aug 2010
Biomedical Research Engineer
University of Pittsburgh 2007 - Jan 2011
Postdoctoral Fellow
University of Pennsylvania School of Medicine 1999 - 2007
Graduate student / post doctoral researcher
Navisys 1994 - 1999
Software development manager
Education:
University of Pennsylvania School of Medicine 1999 - 2006
PhD, Neuroscience West Chester University of Pennsylvania 1989 - 1991
MS, Computer Science University of Pennsylvania 1985 - 1989
BA, Computer Science, Philosophy FRHS, So Deerfield
Interests:
2004 - 2008 Operated a small, profitable, private business manufacturing and selling medieval re-enactment clothing (Fish Head Fashions, D.B.A.)
Honor & Awards:
2008 - 2010 Grant from the National Institute of Neurological Disorders and Stroke - Training in the Neurobiology of Neurodegenerative Disease (T32 NS07391)
Robin Ashmore Photo 2

Robin Ashmore

View page
Location:
Denver, Colorado
Industry:
Marketing and Advertising
Robin Ashmore Photo 3

Robin Ashmore

View page
Location:
United States
Robin Ashmore Photo 4

Robin Ashmore

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ms. Robin Ashmore
Principal
Amelie Company
Advertising Agencies & Counselors
1905 Sherman, Suite 900, Denver, CO 80203
(303) 832-2700, (303) 832-2797

Publications

Us Patents

Neurological Rehabilitation And Training Method Utilizing Oculomotor, Visual And/Or Vestibular Rehabilitation Tasks On Subjects With Pharmacologically Induced Neuroplasticity

View page
US Patent:
20210330255, Oct 28, 2021
Filed:
May 10, 2021
Appl. No.:
17/316077
Inventors:
- Pittsburgh PA, US
Robin C. Ashmore - Pittsburgh PA, US
Alexander D. Kiderman - Pittsburgh PA, US
Peter Charles Doyle - Sherborn MA, US
International Classification:
A61B 5/00
A61K 31/155
A61K 31/198
A61K 38/27
A61K 45/06
A61B 3/113
A61B 5/11
Abstract:
A Neurological Rehabilitation method utilizing oculomotor, visual and/or vestibular rehabilitation tasks on subjects with pharmacologically induced neuroplasticity comprising the steps of Inducing neuroplasticity in a subject through administering of a neuroplasticity medicament; Providing a oculomotor, visual and vestibular rehabilitation task platform configured to supply visual targets to a subject for oculomotor, visual and vestibular rehabilitation tasks and track and record eye movement of the subject during oculomotor, visual and vestibular rehabilitation tasks; Performing oculomotor, visual and/or vestibular rehabilitation tasks on the platform with subjects during periods of pharmacologically induced neuroplasticity. The neuroplasticity medicament generally is comprising at least one of an antidepressant, a Brain Derived Neuro trophic factor enhancer, a steroid, a psychedelic, valproic acid, NDRI's, lithium carbonate, Metformin, N-Acetylcystine, and Human Growth Hormone.

Objective Testing Of Vergence Dysfunction For Diagnosis And Vergence Recovery Convalescence Using Dynamic Vergence Testing Platform Including 3D Head Mounted Display System With Integrated Eye Tracking Technology

View page
US Patent:
20190082954, Mar 21, 2019
Filed:
Aug 22, 2018
Appl. No.:
16/109485
Inventors:
- Pittsburgh PA, US
Robin C. Ashmore - Pittsburgh PA, US
International Classification:
A61B 3/113
G02B 27/00
G02B 27/01
A61B 3/00
Abstract:
An objective testing of vergence dysfunction comprising the steps of: providing a head mounted goggle based stimulus generating eye tracking unit to the subject; presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test; obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and using the objective physiologic responses to diagnose the presence of vergence dysfunction. On objective portable head mounted goggle based stimulus generating eye tracking unit for vergence testing is discloses as is a method of method of vergence recovery convalescence.

Method And Apparatus For Mtbi Diagnosis Implementing Eye Movement And Pupil Movement Analysis In Objective Vergence Testing

View page
US Patent:
20180242842, Aug 30, 2018
Filed:
Feb 14, 2018
Appl. No.:
15/897137
Inventors:
- Pittsburgh PA, US
- Miami FL, US
Robin C. Ashmore - Pittsburgh PA, US
Alexander Kiderman - Pittsburgh PA, US
International Classification:
A61B 3/113
A61B 3/14
A61B 3/11
A61B 3/00
A61B 5/00
A61B 5/12
Abstract:
An objective screening platform for mTBI screening includes a vergence testing stimulus generator visible to a subject and configures for presenting visual stimulus to a subject which forms an optical target stimulus for at least one vergence test; at least one data acquisition unit for obtaining objective physiologic responses of the subject unit based upon each of the visual stimulus presented to the subject in each test, wherein the objective physiologic responses for each test include at least one eye position parameter and at least one pupil area parameter; and a controller configured for using at least one eye position parameter and at least one pupil area parameter to screen for the presence of mTBI of the subject
Control profile
Robin C Ashmore from Pittsburgh, PA, age ~57 Get Report